Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

Author(s):
Baeten, D.; Baraliakos, X.; Braun, J.; Sieper, J.; Emery, P.; Heijde, D. van der; McInnes, I.; Laar, J.M. van; Landewe, R.; Wordsworth, P.; Wollenhaupt, J.; Kellner, H.; Paramarta, J.; Wei, J.W.; Brachat, A.; Bek, S.; Laurent, D.; Li, Y.L.; Wang, Y.A.; Bertolino, A.P.; Gsteiger, S.; Wright, A.M.; Hueber, W.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-11-23
Language
English
Is part of
Lancet (2013), Vol. 382, no. 9906, p. 1705-1713
hdl
1887/99949
doi
10.1016/S0140-6736(13)61134-4